Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Sep-24 7:18 PM View:  | Bioxcel Therapeutics, Inc. (BTAI) | 16-Sep-24 | Planned Option Sale | 215 | $0.69 | $148.52 | (5%) 4.25K to 4.03K | |
| 17-Sep-24 7:18 PM View: | Bioxcel Therapeutics, Inc. (BTAI) | 15-Sep-24 | Option Exercise | 750 | -- | -- | 21% 3.5K to 4.25K | |
| 08-Apr-24 7:31 PM View: | Bioxcel Therapeutics, Inc. (BTAI) | 04-Apr-24 | Planned Option Sale | 1,008 | $2.64 | $2,656.18 | (25%) 4.0K to 2.99K | |
| 08-Apr-24 7:31 PM View: | Bioxcel Therapeutics, Inc. (BTAI) | 15-Mar-24 | Option Exercise | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 02-Apr-21 12:15 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-21 | Payment of Exercise | 2,573 | $6.84 | $17,599.30 | (2%) 116.97K to 114.4K | (1%) |
| 24-Feb-21 4:40 PM View: | Vyne Therapeutics Inc. (VYNE) | 22-Feb-21 | Grant | 27,675 | -- | -- | 31% 89.3K to 116.97K | |
| 05-Jan-21 4:32 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Dec-20 | Payment of Exercise | 1,541 | $1.58 | $2,434.78 | (< 1%) 358.72K to 357.18K | 12% |
| 02-Dec-20 4:31 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Nov-20 | Grant | 7,838 | $1.45 | $11,325.90 | 2% 350.88K to 358.72K | |
| 02-Oct-20 4:32 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Sep-20 | Payment of Exercise | 1,541 | $1.66 | $2,558.06 | (< 1%) 352.43K to 350.88K | (6%) |
| 02-Jul-20 4:25 PM View: | Vyne Therapeutics Inc. (VYNE) | 30-Jun-20 | Payment of Exercise | 1,541 | $1.73 | $2,665.93 | (< 1%) 353.97K to 352.43K | (3%) |
| 08-May-20 5:54 PM View: | Vyne Therapeutics Inc. (VYNE) | 06-May-20 | Grant | 150,000 | -- | -- | 74% 203.97K to 353.97K | |
| 07-Apr-20 5:23 PM View: | Vyne Therapeutics Inc. (VYNE) | 06-Apr-20 | Payment of Exercise | 908 | $1.40 | $1,271.20 | (< 1%) 204.88K to 203.97K | (27%) |
| 07-Apr-20 5:23 PM View: | Vyne Therapeutics Inc. (VYNE) | 03-Apr-20 | Grant | 137,824 | -- | -- | 206% 67.05K to 204.88K | |
| 02-Apr-20 4:41 PM View: | Vyne Therapeutics Inc. (VYNE) | 31-Mar-20 | Payment of Exercise | 525 | $2.68 | $1,407.00 | (< 1%) 67.58K to 67.05K | 34% |
| 11-Mar-20 5:41 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 09-Mar-20 | Disposition | 114,074 | -- | -- | (100%) 114.07K to 0 | |
| 11-Mar-20 5:57 PM View: | Vyne Therapeutics Inc. (VYNE) | 09-Mar-20 | Grant | 67,576 | -- | -- | 100% 0 to 67.58K | |
| 03-Mar-20 4:39 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 02-Mar-20 | Grant | 1,993 | $2.68 | $5,336.26 | 2% 112.08K to 114.07K | (< 1%) |
| 24-Feb-20 6:39 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 24-Feb-20 | Grant | 41,299 | -- | -- | 58% 70.78K to 112.08K | |
| 03-Jan-20 5:24 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 31-Dec-19 | Payment of Exercise | 2,500 | $3.28 | $8,200.00 | (3%) 73.28K to 70.78K | |
| 03-Dec-19 4:31 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 29-Nov-19 | Grant | 9,842 | $2.16 | $21,248.90 | 16% 63.44K to 73.28K | |
| 06-Mar-19 4:07 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 05-Mar-19 | Market Purchase | 13,440 | $3.76 | $50,534.40 | 27% 50.0K to 63.44K | 2% |
| 04-Dec-18 4:05 PM View: | Foamix Pharmaceuticals Ltd. (FOMX) | 03-Dec-18 | Grant | 50,000 | -- | -- | 100% 0 to 50.0K |